VRTX
Vertex Pharmaceuticals
November 2, 2026 · after-hours
- Rarity
- 1.26
- Peak move
- +4.49%
- Float cap
- $140.8B
Vertex Pharmaceuticals is a Boston-based global biotechnology company that discovers, develops, and commercializes medicines for serious diseases, with a focus on specialty markets. Its approved therapies treat cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, acute pain, and acromegaly, sold to patients, hospitals, and health systems worldwide. It also funds research in kidney disease, type 1 diabetes, and neuropathic pain.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.